Genetic Polymorphism in N-Acetyltransferase (NAT): Population Distribution of NAT1 and NAT2 Activity

REFERENCES

• Asprodini , E. K. , Zifa , E. , Papageorgiou , I. and Benakis , A. 1998 . Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe . Eur. J. Drug Metab. Pharmacokinet. , 23 : 501 – 506 .
   PubMedGoogle Scholar
• Badawi , A. F. , Hirvonen , A. , Bell , D. , Lang , N. and Kadlubar , F. 1995 . Role of aromatic amine acetyltransferases, NAT1 and NAT2 in carcinogen–DNA adduct formation in the human urinary bladder . Cancer Res. , 55 : 5230 – 5237 .
   PubMed Web of Science ®Google Scholar
• Bechtel , Y. C. , Bonaiti-Pellie , C. , Poisson , N. , Magnette , J. and Bechtel , P. R. 1993 . A population and family study of N-acetyltransferase using caffeine urinary metabolites . Clin. Pharmacol. Ther. , 54 : 134 – 141 .
   PubMed Web of Science ®Google Scholar
• Bell , D. A. , Taylor , J. A. , Butler , M. , Stephens , E. , Wiest , J. , Brubaker , L. H. , Kadlubar , F. and Lucier , G. W. 1993 . Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans . Carcinogenesis , 14 : 1689 – 1692 .
   PubMed Web of Science ®Google Scholar
• Bell , D. A. , Badawi , A. , Lang , N. , Ilett , K. F. , Kadlubar , F. and Hirvonen , A. 1995a . Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1∗10 allele with higher N-acetylation activity in bladder and colon tissue . Cancer Res. , 55 : 5226 – 5229 .
   PubMed Web of Science ®Google Scholar
• Bell , DA. , Stephens , E. , Castrianio , T. , Umbach , D.M. , Watson , M. , Deakin , M. , Elder , J. , Hendrickse , C. , Duncan , H. and Strange , R. C. 1995b . Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases the risk of colorectal cancer . Cancer Res. , 55 : 3537 – 3542 .
   PubMed Web of Science ®Google Scholar
• Bicho , M. P. , Breitenfeld , L. , Carvalho , A. A. and Manso , C. F. 1988 . Acetylation phenotypes in patients with bladder carcinoma . Ann. Genet. , 31 : 167 – 171 .
   PubMedGoogle Scholar
• Birner , G. , Vamvakas , S. , Dekant , W. and Henschler , D. 1993 . Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethene exposure in humans: Implications for the risk of trichloroethene exposure . Environ. Health Perspect. , 99 : 281 – 284 .
   PubMed Web of Science ®Google Scholar
• Blum , M. , Grant , D. M. , McBride , W. , Heim , M. and Meyer , U. A. 1990 . Human arlyamine N-acetyltransferase genes: Isolation, chromosomal localization, and functional expression . DNA Cell Biol. , 9 : 193 – 203 .
   PubMed Web of Science ®Google Scholar
• Bois , F.Y. , Krowech , G. and Zeise , L. 1995 . Modeling human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl . Risk Anal. , 15 : 205 – 213 .
   PubMed Web of Science ®Google Scholar
• Borlak , J. and Reamon-Buettner , S. M. 2006a . N-Acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease . BMC Med. Genet. , 7 : 30
   PubMedGoogle Scholar
• Borlak , J. and Reamon-Buettner , S. M. 2006b . N-Acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients . BMC Med. Genet. , 7 : 58
   PubMed Web of Science ®Google Scholar
• Bouchardy , C. , Mitrunen , K. , Wikman , H. , Husgafvel-Pursiainen , K. , Dayer , P. , Benhamou , S. and Hirvonen , A. 1998 . N-Acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk . Pharmacogenetics , 8 : 291 – 298 .
   PubMedGoogle Scholar
• Boukouvala , S. and Fakis , G. 2005 . Arylamine N-acetyltransferases: What we learn from genes and genomes . Drug Metab. Rev. , 37 : 511 – 564 .
   PubMed Web of Science ®Google Scholar
• Boukouvala , S. , Price , N. and Sim , E . 2002 . Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice . Pharmacogenetics , 12 : 385 – 394 .
   PubMedGoogle Scholar
• Brockmöller , J. , Cascorbi , I. , Kerb , R. and Roots , I. 1996 . Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk . Cancer Res. , 56 : 3915 – 3925 .
   PubMed Web of Science ®Google Scholar
• Brockmöller , J. , Cascorbi , I. , Kerb , R. , Sachse , C. and Roots , I. 1998 . Polymorphisms in xenobiotic conjugation and disease predisposition . Toxicol. Lett. , 102–103 : 173 – 183 .
   PubMedGoogle Scholar
• Brocton , N. , Little , J. , Sharp , L. and Cotton , SC. 2000 . N-Acetyltransferase polymorphisms and colorectal cancer: A huge review . Am. J. Epidemiol. , 151 : 846 – 861 .
   PubMedGoogle Scholar
• Bruhn , C. , Brockmöller , J. , Cascorbi , I. , Roots , I. and Borchert , H.-H. 1999 . Corelation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1) . Biochem. Pharmacol. , 58 : 1759 – 1764 .
   PubMed Web of Science ®Google Scholar
• Carmichael , S. L. , Shaw , G. M. , Yang , W. , Iovannisci , D. M. and Lammer , E.. 2006 . Risk of limb deficiency defects associated with NAT1, NAT2, GSTT1, GSTM1, and NOS3 genetic variants, maternal smoking, and vitamin supplement intake . Am. J. Med. Genet. A , 140 : 1915 – 1922 .
   PubMed Web of Science ®Google Scholar
• Carreón , T. , Ruder , A. M. , Schulte , P. A. , Hayes , R. B. , Rothman , N. , Waters , M. , Grant , D. J. , Boissy , R. , Bell , D. A. , Kadlubar , F. F. , Hemstreet , G. P. 3rd , Yin , S. and LeMasters , G. K. 2006 . NAT2 slow acetylation and bladder cancer in workers exposed to benzidine . Int. J. Cancer , 118 : 161 – 168 .
   PubMed Web of Science ®Google Scholar
• Cartwright , R. A. , Rogers , H. J. , Barham-Hall , D. , Glashan , R. W. , Ahmad , R. A. , Higgins , E. and Kahn , M. 1982 . Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer . Lancet , 2 : 842 – 845 .
   PubMed Web of Science ®Google Scholar
• Cascorbi , I. and Roots , I. 1999 . Pitfalls in N-acetyltransferase 2 genotyping . Pharmacogenetics , 9 : 123 – 127 .
   PubMedGoogle Scholar
• Cascorbi , I. , Drakoulis , N. , Brockmöller , J. , Mauer , A. , Sperling , K. and Roots , I. 1995 . Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated caucasian individuals: Correlation with phenotypic activity . Am. J. Hum. Genet. , 57 : 581 – 592 .
   PubMed Web of Science ®Google Scholar
• Cascorbi , I. , Roots , I. and Brockmöller , J. 2001 . Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: Significantly reduced risk in subjects with NAT1∗10 . Cancer Res , 61 : 5051 – 5056 .
   PubMed Web of Science ®Google Scholar
• Chen , M. , Xia , B. , Chen , B. , Guo , Q. , Li , J. , Ye , M. and Hu , Z. 2007 . N-Acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease . Can. J. Gastroenterol. , 21 : 155 – 158 .
   PubMed Web of Science ®Google Scholar
• Cribb , A. E. , Isbrucker , R. , Levatte , T. , Tsui , B. , Gillespie , C. T. and Renton , K. W. 1994 . Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlated with a marker of systematic NAT1 activity . Pharmacogenetics , 4 : 166 – 170 .
   PubMedGoogle Scholar
• Dalhoff , K. , Buus Jensen , K. and Enghusen Poulsen , H. 2005 . Cancer and molecular biomarkers of phase 2 . Methods Enzymol. , 400 : 618 – 627 .
   PubMed Web of Science ®Google Scholar
• Deloménie , C. , Sica , L. , Grant , D. M. , Krishnamoorthy , R. and Dupret , J.-M. 1996 . Genotyping of the polymorphic N-acetyltransferase (NAT∗) gene locus in two native African populations . Pharmacogenetics , 6 : 177 – 185 .
   PubMedGoogle Scholar
• Delort , L. , Chalabi , N. , Satih , S. , Rabiau , N. , Kwiatkowski , F. , Bignon , Y. J. and Bernard-Gallon , D. J. 2008 . Association between genetic polymorphisms and ovarian cancer risk . Anticancer Res. , 28 : 3079 – 3081 .
   PubMed Web of Science ®Google Scholar
• Dewan , A. , Chattopadhyay , P. and Kulkarni , P. K. 1995 . N-Acetyltransferase activity—A susceptibility factor in human bladder carcinogenesis . Indian J. Cancer , 32 : 15 – 19 .
   PubMedGoogle Scholar
• Doll , M. A. , Jiang , W. , Deitz , A. C. , Rustan , T. D. and Hein , D. W. 1997 . Identification of a novel allele at the human NAT1 acetyltrasferse locus . Biochem. Biophys. Res. Commun. , 233 : 584 – 591 .
   PubMed Web of Science ®Google Scholar
• Duffel , M. W. and Jakoby , W. B. 1982 . Cysteine S-conjugate N-acetyltransferase from rat kidney microsomes . Mol. Pharmacol. , 21 : 444 – 448 .
   PubMed Web of Science ®Google Scholar
• Evans , D. A. P. , Eze , L. C. and Whibley , E. J. 1983 . The association of the slow acetylator phenotype with bladder cancer . J. Med. Genet. , 20 : 330 – 333 .
   PubMed Web of Science ®Google Scholar
• Estrada-Rodgers , L. , Levy , G. N. and Weber , W. W. 1998 . Substrate selectivity of mouse N-acetyltransferases 1,2 and 3 expressed in COS-1 cells . Drug Metab. Dispos. , 26 : 502 – 505 .
   PubMed Web of Science ®Google Scholar
• Fakis , G. , Boukouvala , S. , Kawamura , A. and Kennedy , S. 2007 . Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis . Pharmacogenet. Genom. , 17 : 181 – 188 .
   PubMed Web of Science ®Google Scholar
• Filiadis , I. F. , Georgiou , I. , Alamanos , Y. , Kranas , V. , Giannakopoulos , X. and Lolis , D. 1999 . Genotypes of N-acetyltransferase-2 and risk of bladder cancer: A case-control study . J. Urol. , 161 : 1672 – 1675 .
   PubMed Web of Science ®Google Scholar
• Fretland , A. J. , Doll , M. A. , Gray , K. , Feng , Y. and Hein , D. W. 1997 . Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: Functional characterization of the activation and deactivation of aromatic amine carcinogens . Toxicol. Appl. Pharmacol. , 142 : 360 – 366 .
   PubMed Web of Science ®Google Scholar
• García-Closas , M. , Malats , N. , Silverman , D. , Dosemeci , M. , Kogevinas , M. , Hein , D. W. , Tardón , A. , Serra , C. , Carrato , A. , García-Closas , R. , Lloreta , J. , Castaño-Vinyals , G. , Yeager , M. , Welch , R. , Chanock , S. , Chatterjee , N. , Wacholder , S. , Samanic , C. , Torà , M. , Fernández , F. , Real , F. X. and Rothman , N. 2005 . NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish bladder cancer study and meta-analyses . Lancet , 366 : 610 – 612 .
   PubMedGoogle Scholar
• Garte , S. , Gaspari , L. , Alexandrie , A.-K. , Ambrosone , C. , Autrup , H. , Autrup , J. L. , Baranova , H. , Bathum , L. , Benhamou , S. , Boffetta , P. , Bouchardy , C. , Breskvar , K. , Brockmoller , J. , Cascorbi , I. , Clapper , M. L. , Coutelle , C. , Daly , A. , Dell'Omo , M. , Dolzan , V. , Dresler , C. M. , Fryer , A. , Haugen , A. , Hein , D. W. , Hildesheim , A. , Hirvonen , A. , Hsieh , L. L. , Ingelman-Sundberg , M. , Kalina , I. , Kang , D. , Kihara , M. , Kiyohara , C. , Kremers , P. , Lazarus , P. , Le Marchand , L. , Lechner , M.C. , van Lieshout , E. M. , London , S. , Manni , J. J. , Maugard , C. M. , Morita , S. , Nazar-Stewart , V. , Noda , K. , Oda , Y. , Parl , F. F. , Pastorelli , R. , Persson , I. , Peters , W. H. , Rannug , A. , Rebbeck , T. , Risch , A. , Roelandt , L. , Romkes , M. , Ryberg , D. , Salagovic , J. , Schoket , B. , Seidegard , J. , Shields , P. G. , Sim , E. , Sinnet , D. , Strange , R. C. , Stücker , I. , Sugimura , H. , To-Figueras , J. , Vineis , P. , Yu , M. C. and Taioli , E. 2001 . Metabolic gene polymorphism frequencies in control populations . Cancer Epidemiol. Biomarkers Prev. , 10 : 1239 – 1248 .
   PubMed Web of Science ®Google Scholar
• Goodfellow , G. H. , Dupret , J. M. and Grant , D. M. 2000 . Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2 . Biochem. J. , 348 : 159 – 166 .
   PubMed Web of Science ®Google Scholar
• Grant , D. M. , Blum , M. and Meyers , U. A. 1992 . Polymorphisms of N-acetyltransferase genes . Xenobiotica , 22 : 1073 – 1081 .
   PubMed Web of Science ®Google Scholar
• Grant , D. M. , Hughes , N. C. , Janezic , S. A. , Goodfellow , G. H. , Chen , H. J. , Gaedigk , A. , Yu , V. L. and Grewal , R. 1997 . Human acetyltransferase polymorphisms . Mutat. Res. , 376 : 61 – 70 .
   PubMed Web of Science ®Google Scholar
• Green , J. , Banks , E. , Berrington , A. , Darby , S. , Deo , H. and Newton , R. 2000 . N-Acetyltransferase 2 and bladder cancer: An overview and consideration of the evidence for gene–environment interaction . Br. J. Cancer , 83 : 412 – 417 .
   PubMed Web of Science ®Google Scholar
• Gross , M. , Kruisselbrink , T. , Anderson , K. , Lang , N. , McGovern , P. , Delongchamp , R. and Kadlubar , F. 1999 . Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population . Cancer Epidemiol. Biomarkers Prev. , 8 : 683 – 692 .
   PubMed Web of Science ®Google Scholar
• Gu , J. , Liang , D. , Wang , Y. , Lu , C. and Wu , X. 2005 . Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians . Mutat. Res. , 581 : 97 – 104 .
   PubMed Web of Science ®Google Scholar
• Hanna , P. E. 1996 . Metabolic activation and detoxification of arylamines . Curr. Med. Chem. , 3 : 195 – 210 .
   Web of Science ®Google Scholar
• Hanssen , H.-P. , Agarwal , D. P. , Goedde , H. W. , Bucher , H. , Huland , H. , Brachmann , W. and Ovenbeck , R. 1985 . Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis: Study in a North German population . Eur. Urol. , 11 : 263 – 266 .
   PubMed Web of Science ®Google Scholar
• Hattis , D. , Banati , P. , Goble , R. and Burmaster , D. E. 1999 . Human inter-individual variability in parameters related to health risks . Risk Anal. , 19 : 711 – 725 .
   PubMed Web of Science ®Google Scholar
• He , L. J. , Yu , Y. M. , Qiao , F. , Liu , J. S. , Sun , X. F. and Jiang , L. L. 2005 . Genetic polymorphisms of N-acetyltransferase 2 and colorectal cancer risk . World J. Gastroenterol. , 11 : 4268 – 4271 .
   PubMedGoogle Scholar
• Hein , D. W. 1988 . Acetylator genotype and arylamine-induced carcinogenesis . Biochim. Biophys. Acta , 948 : 37 – 66 .
   PubMed Web of Science ®Google Scholar
• Hein , D. W. 2006 . N-Acetyltransferase 2 genetic polymorphism: Effects of carcinogen and haplotype on urinary bladder cancer risk . Oncogene , 25 : 1649 – 1658 .
   PubMed Web of Science ®Google Scholar
• Hein , D. W. , Ferguson , R. J. , Doll , M. A. , Rustan , T. D. and Gray , K. 1994 . Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes . Hum. Mol. Genet. , 3 : 729 – 734 .
   PubMed Web of Science ®Google Scholar
• Hein , D. W. , Doll , M. A. , Rustan , T. D. and Ferguson , R. J. 1995 . Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: Effects of specific NAT2 nucleic acid substitutions . Cancer Res. , 55 : 3531 – 3536 .
   PubMed Web of Science ®Google Scholar
• Hein , D. W. , Doll , M. A. , Fretland , A. J. , Leff , M. A. , Webb , S. J. , Xiao , G. H. , Devanaboyina , U.-S. , Nangju , N. A. and Feng , Y. 2000a . Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms . Cancer Epidemiol. Biomarkers Prev. , 9 : 29 – 42 .
   PubMed Web of Science ®Google Scholar
• Hein , D. W. , McQueen , C. A. , Grant , D. M. , Goodfellow , G. H. , Kadlubar , F. and Weber , W. W. 2000b . Pharmacogenetics of the arylamine N-acetyltransferases: A symposium in honor of Wendell W. Weber . Drug Metab. Dispos. , 28 : 1425 – 1432 .
   PubMed Web of Science ®Google Scholar
• Hein , D. W. , Husain , A. , States , J. and Barker , D. F. 2006 . Regulation of the human arylamine N-acetyltransfeeases: Implications for cancer susceptibility . Toxicol. Sci. , 90 ( suppl.1 ) : 4
   Google Scholar
• Hernandez , A. , Xamena , N. , Surralles , J. , Galofre , P. , Velazquez , A. , Creus , A. and Marcos , R. 2008 . Role of GST and NAT2 polymorphisms in thyroid cancer . J. Endocrinol. Invest. , 31 : 1025 – 1031 .
   PubMed Web of Science ®Google Scholar
• Hsieh , F.-I. , Pu , Y.-S. , Chern , H.-D. , Hsu , L.-I. , Chiou , H.-Y. and Chen , C.-J. 1999 . Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer . Br. J. Cancer , 8 : 537 – 541 .
   Google Scholar
• Huang , C. C. , Chien , W. P. , Wong , R. H. , Cheng , Y. W. , Chen , M. C. and Lee , H. 2009 . NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer . Environ. Mol. Mutagen. , 5 : 127 – 133 .
   Google Scholar
• Huang , C. S. , Chern , H. D. , Shen , C. Y. , Hsu , S. M. and Chang , K. J. 1999 . Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence . Int. J. Cancer , 82 : 175 – 179 .
   PubMed Web of Science ®Google Scholar
• Huang , C. C. , Chien , W. P. , Wong , R. H. , Cheng , Y. W. , Chen , M. C. , Chou , M. C. and Lee , H. 2007 . NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan . Dis. Colon Rectum , 50 : 981 – 989 .
   PubMed Web of Science ®Google Scholar
• Hughes , H. B. , Biehl , J. P. , Jones , A. P. and Schmidt , L. H. 1954 . Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis . Am. Rev. Res. Dis. , 70 : 266 – 273 .
   Google Scholar
• Hughes , N. C. , Janezic , S. A. , McQueen , K. L. , Jewett , M. A. S. , Castranio , T. , Bell , D. A. and Grant , D. M. 1998 . Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe . Pharmacogenetics , 8 : 55 – 66 .
   PubMedGoogle Scholar
• Husain , A. , Zhang , X. , Doll , M. A. , States , J. C. , Barker , D. F. and Hein , D. W. 2007 . Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues . Drug Metab. Dispos. , 35 : 721 – 727 .
   PubMed Web of Science ®Google Scholar
• Ilett , K. F. , Kadlubar , F. F. and Minchin , R. F. 1999 . Synopsis of the workshop on nomenclature, biochemistry, molecular biology, interspecies comparisons, and role in human disease risk . Drug Metab. Dispos. , 27 : 957 – 959 .
   PubMedGoogle Scholar
• Inatomi , H. , Katoh , T. , Kawamoto , T. and Matsumoto , T. 1999 . NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese . Int. J. Urol. , 6 : 446 – 454 .
   PubMed Web of Science ®Google Scholar
• Ishibe , N. , Wiencke , J. K. , Zuo , Z.-F. , McMillan , A. , Spitz , M. R. and Kelsey , K. T. 1998 . Polymorphisms in the N-acetyltransferase 1 (NAT1) gene and lung cancer risk in a minority population . Biomarkers , 3 : 219 – 226 .
   PubMed Web of Science ®Google Scholar
• Jain , M. , Kumar , S. , Lal , P. , Tiwari , A. , Ghoshal , U. C. and Mittal , B. 2007 . Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population . Cancer Invest. , 25 : 340 – 346 .
   PubMed Web of Science ®Google Scholar
• Jenne , J. W. 1964 . Pharmacokinetics and the dose of isoniazid and p-aminosalicylic acid in the treatment of tuberculosis . Antibiotic Chemother. , 12 : 407 – 432 .
   PubMedGoogle Scholar
• Jensen , L. E. , Hoess , K. , Mitchell , L. E. and Whitehead , A. S. 2006 . Loss of function polymorphisms in NAT1 protect against spina bifida . Hum. Genet. , 120 : 52 – 57 .
   PubMed Web of Science ®Google Scholar
• Katoh , T. , Kaneko , S. , Boissy , R. , Watson , M. , Ikemura , K. and Bell , D. A. 1998 . A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people . Carcinogenesis , 19 : 1803 – 1807 .
   PubMed Web of Science ®Google Scholar
• Kim , W.-J. , Lee , H.-L. , Lee , S.-C. , Kim , Y. T. and Kim , H. 2000 . Polymorphisms of N-acetyltransferase 2, gluathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis . J. Urol. , 164 : 209 – 213 .
   PubMedGoogle Scholar
• Klaassen , C. D. , Amdur , M. O. and Doull , J. 1996 . Casarett and Doull's toxicology; The basic science of poisons , 5th , 172 – 175 . New York : McGraw-Hill .
   Google Scholar
• Koizumi , A. , Nomiyama , T. , Tsukada , M. , Wada , Y. , Omae , K. , Tanaka , S. , Miyauchi , H. , Imayiya , S. and Sakurai , H. 1998 . Evidence on N-acetyltransferase allele-associated metabolism of hydrazine in Japanese workers . J. Occup. Environ. Med. , 40 : 217 – 222 .
   PubMed Web of Science ®Google Scholar
• Lash , L. H. , Fisher , J. W. , Lipscomb , J. C. and Parker , J. C. 2000 . Metabolism of trichloroethylene . Environ. Health Perspect. , 108 : 177 – 200 .
   PubMed Web of Science ®Google Scholar
• Lichter , J. , Heckelen , A. , Fischer , K. and Blomeke , B. 2008 . Expression of N-acetyltransferase in monocyte-derived dendritic cells . J. Toxicol. Environ. Health A , 71 : 960 – 964 .
   PubMed Web of Science ®Google Scholar
• Lilla , C. , Verla-Tebit , E. , Risch , A. , Jäger , B. , Hoffmeister , M. , Brenner , H. and Chang- Claude , H. 2006 . Effect of NAT1 and NAT2 genetic polymorphisms on colon cancer risk associated with exposure to tobacco smoke and meat consumption . Cancer Epidemiol. Biomarkers Prev. , 15 : 99 – 107 .
   PubMed Web of Science ®Google Scholar
• Lin , H. J. , Han , C.-Y. , Lin , B. K. and Hardy , S. 1993 . Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: Application to metabolic epidemiology . Am. J. Hum. Genet. , 52 : 827 – 834 .
   PubMed Web of Science ®Google Scholar
• Lower , G. M. 1983 . Molecular epidemiology of arylamine-induced urinary bladder cancer: some theoretical considerations . Fed. Proc. , 42 : 3094 – 3097 .
   Google Scholar
• Lower , G. M. , Nilsson , T. , Nelson , C. E. , Wolf , H. , Gamsky , T. E. and Bryan , G. T. 1979 . N-Acetyltransferase phenotype and risk in urinary bladder cancer: Approaches in molecular epidemiology. Preliminary Results in Sweden and Denmark . Environ. Health Perspect. , 29 : 71 – 79 .
   PubMed Web of Science ®Google Scholar
• Lu , C. M. , Chung , M. C. , Huang , C. H. and Ko , Y. C. 2005 . Interaction effect in bladder cancer between N-acetyltransferase 2 genotype and alcohol drinking . Urol. Int. , 75 : 360 – 364 .
   PubMed Web of Science ®Google Scholar
• Machida , H. , Tsukamoto , K. , Wen , CY. , Shikuwa , S. , Isomoto , H. , Mizuta , Y. , Takeshima , F. , Murase , K. , Matsumoto , N. , Murata , I. , Kohno , S. and Wen , C. Y. 2005 . Crohn's disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene . World J. Gastroenterol. , 11 : 4833 – 4837 .
   PubMedGoogle Scholar
• Mahid , S. S. , Colliver , D. W. , Crawford , N. P. , Martini , B. D. , Doll , M. A. , Hein , D. W. , Cobbs , G. A. , Petras , R. E. and Galandiuk , S. 2007 . Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma . BMC Med. Genet. , 8 : 28
   PubMedGoogle Scholar
• Marcus , P. , Hayes , M. R. , Vineis , P. , Montserrat , G.-C. , Caporaso , N. , Autrup , H. , Branch , R. , Brockmöller , J. , Ishizaki , T. , Karakaya , A. , Ladero , J. , Mommsen , S. , Okkels , H. , Romkes , M. , Roots , I. and Rothman , N. 2000a . Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene–environment interaction . Cancer Epidemiol. Biomarkers Prev. , 89 : 461 – 467 .
   Google Scholar
• Marcus , P. M. , Vineis , P. and Rothman , N. 2000b . NAT2 Slow acetylation and bladder cancer risk: A meta-analysis of 22 case-control studies conducted in the general population . Pharmacogenetics , 10 : 115 – 122 .
   PubMedGoogle Scholar
• McGrath , M. , Michaud , D. and De Vivo , I. 2006 . Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women . BMC Cancer , 6 : 239
   PubMed Web of Science ®Google Scholar
• Metry , K. J. , Zhao , S. , Neale , J. R. , Doll , M. A. , States , J. C. , McGregor , W. G. , Pierce , W. M. Jr. and Hein , D. W. 2007 . 2-Amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced DNA adducts and genotoxicity in Chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2 . Mol. Carcinogen. , 46 : 553 – 563 .
   PubMedGoogle Scholar
• Millikan , R. , Pittman , G. , Newman , B. , Tse , C. , Selmin , O. , Rockhill , B. , Savitz , D. , Moorman , P. and Bell , D. 1998 . Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk . Cancer Epidemiol. Biomarkers Prev. , 7 : 371 – 378 .
   PubMed Web of Science ®Google Scholar
• Mommsen , S. , Barfod , N. M. and Aagaard , J. 1985 . N-Acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population . Carcinogenesis , 6 : 199 – 201 .
   PubMed Web of Science ®Google Scholar
• Morton , L. M. , Schenk , M. , Hein , D. W. , Davis , S. , Zahm , S. H. , Cozen , W. , Cerhan , J. R. , Hartge , P. , Welch , R. , Chanock , S. J. , Rothman , N. and Wang , S. S. 2006 . Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma . Pharmacogenet. Genom. , 16 : 537 – 545 .
   PubMed Web of Science ®Google Scholar
• Nikishina , M. V. , Vavilin , V. A. , Makarova , S. I. and Lyakhovich , V. V. 2007 . Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer . Bull. Exp. Biol. Med. , 143 : 83 – 86 .
   PubMedGoogle Scholar
• Okkels , H. , Sigsgaard , T. , Wolf , H. and Autrup , H. 1997 . Arylamine N-acetyletransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking . Cancer Epidemiol. Biomarkers Prev. , 6 : 225 – 231 .
   PubMed Web of Science ®Google Scholar
• Okumura , K. , Kita , T. , Chikazawa , S. , Komada , F. , Iwakaw , S. and Tanigawara , Y. 1997 . Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism . Clin. Pharmacol. Ther. , 61 : 509 – 517 .
   PubMed Web of Science ®Google Scholar
• Pandey , SN. , Modi , DR. , Choudhuri , G. and Mittall , B. 2007 . Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: The cancer risk not modulated by gallstone disease . Cancer Biol. Ther. , 6 : 91 – 96 .
   PubMed Web of Science ®Google Scholar
• Parkin , D. P. , Vandenplas , S. , Botha , F. J. H. , Vandenplas , M. L. , Seifart , H. J. , van Helden , P. D. , van der Walt , B. J. , Donald , P. R. and Jaarsveld , P. P. 1997 . Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis . Am. J. Respir. Crit. Care Med. , 155 : 1717 – 1722 .
   PubMed Web of Science ®Google Scholar
• Payton , M. A. and Sim , E. 2008 . Genotyping human arylamine N-acetyltransferase type 1 (NAT1): The identification of two novel allelic variants . Biochem. Pharmacol. , 55 : 361 – 366 .
   Google Scholar
• Peluso , M. , Airoldi , L. , Armelle , M. , Martone , T. , Coda , R. , Malaveille , C. , Giacomelli , G. , Terrone , C. , Casetta , G. and Vineis , P. 1998 . White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: A case-control study . Cancer Epidemiol. Biomarkers Prev. , 7 : 341 – 346 .
   PubMed Web of Science ®Google Scholar
• Probst-Hensch , N. M. , Haile , R. W. , Ingles , S. A. , Longnecker , M. P. , Han , C. Y. , Lin , B. K. , Lee , D. B. , Sakamoto , G. T. , Frankl , H. D. and Lee , E. R. 1995 . Acetylation polymorphisms and prevalence of colorectal adenomas . Cancer Res. , 55 : 2017 – 2020 .
   PubMed Web of Science ®Google Scholar
• Probst-Hensch , N. M. , Haile , R. W. , Li , D. S. , Sakamoto , G. T. , Louie , A. D. , Lin , B. K. , Frank , H. D. , Lee , E. R. and Lin , H. J. 1996 . Lack of association between the polyadenylation polymorphism in NAT1 (acetyltransferase 1) gene and colorectal adenomas . Carcinogenesis , 17 : 2125 – 2129 .
   PubMed Web of Science ®Google Scholar
• Relling , M. V. , Lin , J.-S. , Ayers , G. D. and Evans , W. E. 1992 . Racial and gender differences in N-acetyltransferase, xanthine oxidase and CYP1A2∗ activities . Clin. Pharmacol. Ther. , 52 : 643 – 658 .
   PubMed Web of Science ®Google Scholar
• Rihs , H. P. , John , A. , Scherenberg , M. , Seidel , A. and Brüning , T. 2007 . Concordance between the deduced acetylation status generated by high-speed: Real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay . Clin. Chim. Acta , 376 : 240 – 243 .
   PubMedGoogle Scholar
• Risch , A. , Wallace , D. M. A. , Bathers , S. and Sim , E. 1995 . Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer . Hum. Mol. Genet. , 4 : 231 – 236 .
   PubMed Web of Science ®Google Scholar
• Roemer , H. C. , Weistenhofer , W. , Lohlein , D. , Geller , F. , Blomeke , B. and Golka , K . 2008 . N-Acetyltransferase 1 in colon and rectal cancer cases from an industrialized area . J. Toxicol. Environ. Health A , 71 : 902 – 905 .
   PubMed Web of Science ®Google Scholar
• Rothman , N. , Bhatnagar , V. K. , Hayes , R. B. , Zenser , T. V. , Kashyap , S. K. , Butler , M. A. , Bell , D. A. , Lakshmi , V. , Jaeger , M. , Kashyap , R. , Hirvonen , A. , Schulte , P. A. , Dosemeci , M. , Hsu , F. , Parikh , D. J. , Davis , B. B. and Talaska , G. 1996 . The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers . Proc. Natl. Acad. Sci. USA , 93 : 5084 – 5089 .
   PubMed Web of Science ®Google Scholar
• Sabbagh , A. and Darlu , P. 2006 . SNP selection at the NAT2 locus for an accurate prediction of the acetylation phenotype . Genet. Med. , 8 : 76 – 85 .
   PubMed Web of Science ®Google Scholar
• Sanderson , S. , Salanti , G. and Higgins , J. 2007 . Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: A literature-based systematic HuGE review and evidence synthesis . Am. J. Epidemiol. , 166 : 741 – 751 .
   PubMed Web of Science ®Google Scholar
• Schnakenberg , E. , Ehlers , C. , Feyerabend , W. , Werdin , R. , Hubotter , R. , Dreikorn , K. and Schloot , W. 1998 . Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients . Clin. Genet. , 53 : 396 – 402 .
   PubMed Web of Science ®Google Scholar
• Schnakenberg , E. , Lustig , M. , Breuer , R. , Werdin , R. and Hubotter , R. 2000 . Gender-specific effects of NAT2 and GSTM1 in bladder cancer . Clin. Genet. , 57 : 270 – 277 .
   PubMedGoogle Scholar
• Shimizu , Y. , Dobashi , K. , Mita , Y. , Endou , K. , Moriya , S. , Osano , K. , Koike , Y. , Higuchi , S. , Yabe , S. , Utsugi , M. , Ishizuka , T. , Hisada , T. , Nakazawa , T. and Mori , M. 2006 . DNA microarray genotyping of N-acetyltransferase 2 polymorphism using carbodiimide as the linker for assessment of isoniazid hepatotoxicity . Tuberculosis , 86 : 374 – 381 .
   PubMedGoogle Scholar
• Sillanpää , P. , Hirvonen , A. , Kataja , V. , Eskelinen , M. , Kosma , V. M. , Uusitupa , M. , Vainio , H. and Mitrunen , K. 2005 . NAT2 slow acetylator genotype as an important modifier of breast cancer risk . Int. J. Cancer , 114 : 579 – 584 .
   PubMed Web of Science ®Google Scholar
• Sim , E. , Westwood , I. and Fullam , E. 2007 . Arylamine N-acetyltransferases . Expert Opin. Drug Metab. Toxicol. , 3 : 169 – 184 .
   PubMed Web of Science ®Google Scholar
• Sim , E. , Lack , N. , Wang , C. J. , Long , H. , Westwood , I. , Fullam , E. and Kawamura , A. 2008 . Arylamine N-acetyltransferases: Structural and functional implications of polymorphisms . Toxicology , 254 : 170 – 183 .
   PubMed Web of Science ®Google Scholar
• Slattery , M. L. , Wolff , R. K. , Curtin , K. , Fitzpatrick , F. , Herrick , J. , Potter , J. D. , Caan , B. J. and Samowitz , W. S. 2009 . Colon tumor mutations and epigenetic changes associated with genetic polymorphism: Insight into disease pathways . Mutat. Res. , 660 : 12 – 21 .
   PubMedGoogle Scholar
• Smith , C. A. D. , Wadelius , M. , Gough , A. C. , Harrison , D. J. , Wolf , C. R. and Rane , A. 1997 . A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid . J. Med. Genet. , 34 : 758 – 760 .
   PubMed Web of Science ®Google Scholar
• Sugamori , K. S. , Brenneman , D. , Wong , S. , Gaedigk , A. , Yu , V. , Abramovici , H. , Rozmahel , R. and Grant , D. M. 2007 . Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse . Toxicol. Sci. , 99 : 413 – 421 .
   PubMedGoogle Scholar
• Taylor , J. A. , Umbach , D. , Stephens , E. , Castrianio , T. , Paulson , D. , Robertson , C. , Mohler , J. and Bell , D. A. 1998 . The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene–gene–exposure three-way interaction . Cancer Res. , 58 : 3603 – 3610 .
   PubMed Web of Science ®Google Scholar
• Van Eyken , E. , Van Camp , G. , Fransen , E. , Topsakal , V. , Hendrickx , J. J. , Demeester , K. , Van de Heyning , P. , Maki-Torkko , E. , Hannula , S. , Sorri , M. , Jensen , M. , Parving , A. , Bille , M. , Baur , M. , Pfister , M. , Bonaconsa , A. , Mazzoli , M. , Orzan , E. , Espeso , A. , Stephens , D. , Verbruggen , K. , Huyghe , J. , Dhooge , I. , Huygen , P. , Kremer , H. , Cremers , C. W. , Kunst , S. , Manninen , M. , Pyykko , I. , Lacava , A. , Steffens , M. , Wienker , T. F. and Van Laer , L. 2007 . Contribution of the N-acetyltransferase 2 polymorphism NAT2∗6A to age-related hearing impairment . J. Med. Genet. , 44 : 570 – 578 .
   PubMedGoogle Scholar
• Vatsis , K. , Weber , W. W. , Bell , D. A. , Dupret , J.-M. , Evans , D. A. P. , Grant , D. M. , Hein , D. W. , Sim , E. , Suzuki , T. and Yasushi , Y. 1995 . Nomenclature for N-acetyltransferases . Pharmacogenetics , 5 : 1 – 17 .
   PubMedGoogle Scholar
• Vaziri , S. A. J. , Hughes , N. C. , Sampson , H. , Darling , G. , Jewett , M. A. S. and Grant , D. M. 2001 . Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects . Pharmacogenetics , 11 : 7 – 20 .
   PubMedGoogle Scholar
• Vineis , P. , Marinelli , D. , Autrup , H. , Brockmoller , J. , Cascorbi , I. , Daly , A. K. , Golka , K. , Okkels , H. , Risch , A. , Rothman , N. , Sim , E. and Taioli , E. 2001 . Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: A pooled analysis of genotype-based studies . Cancer Epidemiol. Biomarkers Prev. , 10 : 1249 – 1252 .
   PubMed Web of Science ®Google Scholar
• Walraven , J. M. , Barker , D. F. , Doll , M. A. and Hein , D. W. 2007 . Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and Functional characterization of a novel rNat3∗2 genetic variant . Toxicol. Sci. , 99 : 413 – 421 .
   PubMed Web of Science ®Google Scholar
• Weber , W. W. and Hein , D. W. 1979 . Clinical pharmacokinetics of isoniazid . Clin. Pharmacokinet. , 4 : 401 – 422 .
   PubMed Web of Science ®Google Scholar
• Weber , W. W. and Hein , D. W. 1985 . N-Acetylation pharmacogenetics . Pharmacol. Rev. , 37 : 25 – 79 .
   PubMed Web of Science ®Google Scholar
• Weistenhofer , W. , Blaszkewicz , M. , Bolt , H. M. and Golka , K. 2008 . N-Acetyltransfrease 2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany . J. Toxicol. Environ. Health A , 71 : 906 – 910 .
   PubMed Web of Science ®Google Scholar
• Welfare , M. R. , Cooper , J. , Bassendine , M. F. and Daly , A. K. 1997 . Relationship between acetylator status, smoking, diet, and colorectal cancer risk in the northeast of England . Carcinogenesis , 18 : 1372 – 1374 .
   Google Scholar
• Windmill , K. F. , McKinnon , R. A. , Zhu , X. , Gaedigk , A. , Grant , D. M. and McManus , M. E. 1997 . The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: Functional and localization studies . Mutat. Res. , 376 : 153 – 160 .
   PubMed Web of Science ®Google Scholar
• Yang , M. , Katoh , T. , Delongchamp , R. , Ozawa , S. , Kohshi , K. and Kawamoto , T. 2000 . Relationship between NAT1 genotype and phenotype in a Japanese population . Pharmacogenetics , 10 : 225 – 232 .
   PubMedGoogle Scholar
• Zang , Y. , Zhao , S. , Doll , M. A. , Christopher States , J. and Hein , D. W. 2007a . Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2 . Pharmacogenet. Genom. , 17 : 37 – 45 .
   PubMed Web of Science ®Google Scholar
• Zang , Y. , Doll , MA. , Zhao , S. , States , J. C. and Hein , D. W. 2007b . Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2 . Carcinogenesis , 28 : 1665 – 1671 .
   PubMed Web of Science ®Google Scholar
• Zhang , X. , Lambert , J. C. , Doll , M. A. , Walraven , J. M. , Arteel , G. E. and Hein , D. W. 2006 . 4,4′-Methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the rat . J. Pharmacol. Exp. Ther. , 316 : 289 – 294 .
   PubMed Web of Science ®Google Scholar
• Zhangwei , X. , Jianming , X. , Qiao , M. and Xinhua , X. 2006 . N-Acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population . Clin. Chim. Acta , 371 : 85 – 91 .
   PubMed Web of Science ®Google Scholar
• Zhao , B. , Lee , E. J. , Yeoh , P. N. and Gong , N. H. 1998 . Detection of mutations and polymorphism of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations . Pharmacogenetics , 8 : 299 – 304 .
   PubMedGoogle Scholar
• Zhao , B. , Seow , A. , Lee , E. J. and Lee , H. P. 2000 . Correlation between acetylation phenotype and genotype in Chinese women . Eur. J. Clin. Pharmacol. , 56 : 689 – 692 .
   PubMed Web of Science ®Google Scholar